<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 2; Issue 1</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Jan-Feb, 2021)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>Radiation Therapy and Non-Hodgkin Lymphoma of the Extremity. Case Reports: Strategy for Treatment Planning and Therapy Implementation</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>6</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Kevin</FirstName>
          <LastName>O’Connor</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>James</FirstName>
          <LastName>Shen</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Ameer</FirstName>
          <LastName>Elaimy</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Rebecca</FirstName>
          <LastName>Wang</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Linda</FirstName>
          <LastName>Ding</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Harry</FirstName>
          <LastName>Bushe</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Carla</FirstName>
          <LastName>Bradford</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>I-Lin</FirstName>
          <LastName>Kuo</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Yankhua</FirstName>
          <LastName>Fan</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Abdulnasser</FirstName>
          <LastName>Khalifeh</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Fenhong</FirstName>
          <LastName>Liu</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Suhong</FirstName>
          <LastName>Yu</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Jonathan</FirstName>
          <LastName>Saleeby</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Samantha</FirstName>
          <LastName>Boudreau</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Erica</FirstName>
          <LastName>Smith</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Paul</FirstName>
          <LastName>Rava</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Shirin</FirstName>
          <LastName>Sioshansi</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Eric</FirstName>
          <LastName>Ko</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Daniel</FirstName>
          <LastName>Han</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>M. Giulia</FirstName>
          <LastName>Cicchetti</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Janaki</FirstName>
          <LastName>Moni</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Allison</FirstName>
          <LastName>Sacher</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Jesse</FirstName>
          <LastName>Aronowitz</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Doreen</FirstName>
          <LastName>Brettler</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Lacey</FirstName>
          <LastName>McIntosh</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Bruce</FirstName>
          <LastName>Woda</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Jacob</FirstName>
          <LastName>Bledsoe</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Mathew</FirstName>
          <LastName>Most</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Maryann</FirstName>
          <LastName>Bishop–Jodoin</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Thomas J</FirstName>
          <LastName>FitzGerald</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Radiation therapy delivered with definitive intent is challenging in the treatment of malignancies involving the extremities. Often, the target volume of interest is circumferential in the extremity compartment and sparing normal tissue and providing conformal avoidance to bone/soft tissue is difficult to achieve. In this manuscript we review the use of volumetric modulated arc therapy (VMAT) to provide concurrent and simultaneous radiation treatment to tumors in both anterior and posterior compartments including the popliteal fossa with appropriate sparing of normal tissue for lymphatic drainage. The use of advanced therapy technology can make a significant difference in the comprehensive management of patients with both epithelial and non-epithelial non-Hodgkin lymphoma lesions in the extremities.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Radiation Therapy,Non-Hodgkin Lymphoma,Therapy Implementation</Keywords>
      <URLs>
        <Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=9114&amp;title=Radiation Therapy and Non-Hodgkin Lymphoma of the Extremity. Case Reports: Strategy for Treatment Planning and Therapy Implementation</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Christiansen S, Cohen P, Broome C. A case series of non-Hodgkin’s lymphoma recurrence in lower extremities mimicking deep vein thrombosis. Blood 2016; 128: 5344.&#13;
&#13;
Dargent JL, Lespagnard L, Feoli F, Debusscher L, Greuse M, Bron D. De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema. Leukemia and; Lymphoma 2005; 46: 775-780.&#13;
&#13;
Gonzalez-Vela MC, Gonzalez-Lopez MA, Val-Bernal J, Fernandez-Llaca H. Cutaneous diffuse B cell lymphoma of the leg associated with chronic lymphedema. International Journal of Dermatology 2008; 47: 174-177.&#13;
&#13;
Ishii N, Aoki M, Kishi K. Lymphedema of the lower extremities due to refractory malignant lymphoma treated by lymphaticovenous anastomosis. Plastic Reconstructive Surgery Global Open 2017; pp: e1475.&#13;
&#13;
Persky DO, Unger JM, Spier CM, Stea B, LeBlanc M, McCarty MJ, Rimsa LM, Fisher RI, Miller TP, Southwest Oncology Group. Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. Journal of Clinical Oncology 2008; 26: 2258-2263.&#13;
&#13;
Tiwana M, Barnes M, Kiraly A, Olson R. Utilization of palliative radiotherapy for bone metastasis near end of life in a population-based cohort. BMC Palliative Care 2016; 15: 2.&#13;
&#13;
Tokumaru S, Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Yamauchi C, Suzuki O, Sakurai H, Teshima T, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N, Kudo S. Insufficiency fractures after pelvic radiation therapy for uterine cervical cancer: an analysis of subjects in a prospective multi-institutional trial and cooperative study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG). International Journal of Radiation Oncology, Biology, Physics 2012; 84: 195-200.&#13;
&#13;
Torres-Paoli D, Sanchez JL. Primary cutaneous B-cell lymphoma of the leg in a chronic lymphedematous extremity. American Journal of Dermatopathology 2000; 22: 257-260.&#13;
&#13;
Zheng X, Dai T, Shu X, Pu Y, Feng G, Li X, Liao D, Du X. A new method of lower extremity immobilization in radiotherapy. Radiation Oncology 2012; 7: 27.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>